Walleye Trading
BBIO icon

Walleye Trading’s BridgeBio Pharma BBIO Stock Holding History

Walleye Trading’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.1K Sell
500
-12,000
-96% -$870K ﹤0.01% 3750
2025
Q4 		$956K Buy
12,500
+9,500
+317% +$624K ﹤0.01% 2407
2025
Q3 		$156K Sell
3,000
-4,400
-59% -$215K ﹤0.01% 3499
2025
Q2 		$320K Sell
7,400
-13,300
-64% -$484K ﹤0.01% 2949
2025
Q1 		$716K Sell
20,700
-4,500
-18% -$152K ﹤0.01% 2276
2024
Q4 		$691K Buy
+25,200
New +$651K ﹤0.01% 2393
2024
Q3 		– Sell
-10,000
Closed -$253K – 4107
2024
Q2 		$253K Sell
10,000
-50,300
-83% -$1.38M ﹤0.01% 2938
2024
Q1 		$1.86M Buy
60,300
+58,800
+3,920% +$2M ﹤0.01% 1773
2023
Q4 		$60.6K Sell
1,500
-14,800
-91% -$444K ﹤0.01% 4292
2023
Q3 		$430K Buy
16,300
+12,400
+318% +$352K ﹤0.01% 3071
2023
Q2 		$67.1K Sell
3,900
-30,800
-89% -$463K ﹤0.01% 3879
2023
Q1 		$575K Buy
+34,700
New +$405K ﹤0.01% 2672
2022
Q3 		– Sell
-100
Closed -$1K – 5038
2022
Q2 		$1K Sell
100
-7,900
-99% -$66.1K ﹤0.01% 4996
2022
Q1 		$81K Buy
+8,000
New +$82.1K ﹤0.01% 4343
2021
Q3 		– Sell
-19,055
Closed -$1.16M – 5216
2021
Q2 		$1.16M Sell
19,055
-185
-1% -$10.6K ﹤0.01% 1989
2021
Q1 		$1.19M Buy
+19,240
New +$1.26M 0.01% 1757

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's BBIO Position: Q1 2026 in Review

Walleye Trading reduced its BridgeBio Pharma (BBIO) stake by 58% in Q1 2026, selling an estimated $173K and leaving 1,745 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

Walleye Trading first reported a position in BBIO in Q1 2021 and has held it in 11 quarters since. The position peaked at $489K in Q2 2023. 457 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Walleye Trading held 1,745 shares of BridgeBio Pharma worth $130K as of Q1 2026.
  • Walleye Trading sold 2,386 BridgeBio Pharma shares in Q1 2026, an estimated $173K.
  • BridgeBio Pharma made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3336 holding.
  • Walleye Trading first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 11 quarters since.
  • Walleye Trading's BridgeBio Pharma position peaked at $489K in Q2 2023.
  • 457 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.